Ryan D Morrison Selected Research

Ryan D Morrison Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 09/2010
3	Catalepsy 01/2016 - 02/2012
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 02/2012
3	Schizophrenia (Dementia Praecox) 12/2013 - 11/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2020
2	Pain (Aches) 05/2019 - 01/2019
2	Cocaine-Related Disorders (Cocaine Addiction) 03/2016 - 08/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 11/2012
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2016 - 09/2012
2	Central Nervous System Diseases (CNS Diseases) 11/2015 - 09/2013
1	Colitis 09/2022
1	Delirium 11/2019
1	Obesity 10/2019
1	Insulin Resistance 10/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Inflammation (Inflammations) 11/2018
1	Mental Disorders (Mental Disorder) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Parkinsonian Disorders (Parkinsonism) 11/2016
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Dyskinesias (Dyskinesia) 01/2016
1	Human Influenza (Influenza) 12/2014
1	Seizures (Absence Seizure) 09/2013
1	Communicable Diseases (Infectious Diseases) 08/2013
1	Hypoxia (Hypoxemia) 04/2013
1	Diabetes Mellitus 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Autistic Disorder (Autism) 09/2012
1	Neoplasm Metastasis (Metastasis) 09/2010

Drug/Important Bio-Agent (IBA)

5	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016 - 02/2012
3	Haloperidol (Haldol)FDA LinkGeneric 01/2016 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	Analgesics (Analgesic Drugs)IBA 05/2019 - 01/2019
2	VU0466551IBA 05/2019 - 01/2019
2	Morphine (MS Contin)FDA LinkGeneric 05/2019 - 01/2019
2	Metabotropic Glutamate 5 ReceptorIBA 03/2016 - 12/2013
2	Levodopa (L Dopa)FDA LinkGeneric 01/2016 - 02/2012
2	1-dodecylpyridoxal (PLD)IBA 12/2014 - 09/2010
1	HLA-DR alpha-ChainsIBA 01/2023
1	CateninsIBA 09/2022
1	Messenger RNA (mRNA)IBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	2-(aminomethyl)phenolIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2016
1	Therapeutic UsesIBA 01/2016
1	Exenatide (Byetta)FDA Link 12/2014
1	VU0468809IBA 12/2014
1	Antiviral Agents (Antivirals)IBA 12/2014
1	Cytochrome P-450 CYP3AIBA 12/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2013
1	Cocaine (Cocaine HCl)IBA 08/2013
1	VU0463841IBA 08/2013
1	Oxidoreductases (Dehydrogenase)IBA 04/2013
1	Oxygen (Dioxygen)IBA 04/2013
1	ProdrugsIBA 04/2013
1	compound 17IBA 01/2013
1	Prostaglandins EIBA 01/2013
1	ProstaglandinsIBA 01/2013
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2012
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 02/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 02/2012
1	Adenosine (Adenocard)FDA LinkGeneric 02/2012
1	N-(3-chlorophenyl)picolinamideIBA 02/2012
1	Protein Isoforms (Isoforms)IBA 09/2010

Therapy/Procedure

4	Therapeutics 01/2020 - 08/2013
2	Polypharmacy 11/2019 - 01/2017
1	Drug Therapy (Chemotherapy) 03/2016